F2G
Novel Therapeutics for Rare Fungal Infections
Manchester, United Kingdom · $261.0M raised
- Headquarters
- Manchester
- Employees
- 51–200
- Business Model
- B2B
- Website
- f2g.com
- Total Funding
- $261.0M
- Last Round
- $100.0M Venture RoundSep 2024
- Rounds
- 4
About
F2G (Functional Fungal Genomics) is a clinical-stage biopharmaceutical company based in Manchester, UK, focused on developing first-in-class medicines for rare, life-threatening fungal infections. The company discovered and developed the orotomides, a novel class of antifungal agents that selectively target a key enzyme in fungal metabolism, with lead candidate olorofim advancing through late-stage development.
Summary
F2G is a Biotech company based in Manchester, United Kingdom. It has raised $261.0M in total across 4 rounds, most recently a $100.0M Venture Round round in Sep 2024. Investors include Sofinnova Partners, Forbion Capital Partners and Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...